FDA Eyes AngioDynamics Over Surgical Knife Marketing
The Albany, N.Y.-based company revealed Tuesday that it had received the letter, which accused it of making certain statements, including on its website, that promote the use of the NanoKnife system beyond its currently cleared indications.
The NanoKnife system has been approved in the U.S. market and in certain international markets for the surgical ablation of soft tissue.
AngioDynamics said it is...
To view the full article, register now.